On Demand Webinars

Brain organoids serve as avatars for studying human neurobiology and advancing drug discovery for neurological disorders. 

A groundbreaking fusion of flow cytometry and cell imaging pushes the limits of cell examination and sorting. 

T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.

How are scientists incorporating oncolytic viruses into the current cancer treatment landscape? 

Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.

AI simulates how cancer cells respond to therapy, guiding optimal treatment strategies.

Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery. 

Advanced machine learning methods generate de novo therapeutic proteins, unlocking new possibilities for more effective treatments.

Epithelial cells partner with tissue-resident memory cells to protect the lung during Streptococcus pneumoniae infection.

Antibodies that simultaneously target two distinct antigens overcome cancer therapy resistance by addressing antigenic diversity and diminished T cell action. 

Chimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.

Advances in synthetic biology and automation accelerate high throughput antibody screening.